Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes
- PMID: 16735605
- DOI: 10.1124/mol.106.024513
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes
Abstract
Nicotine's modulation of hippocampal noradrenergic neurotransmission may contribute to its mnemonic properties, but the nicotinic acetylcholine receptor (nAChR) subtypes that modulate terminal release of norepinephrine are unknown. In the present study, we used a number of subtype-selective alpha-conotoxins in combination with nicotinic receptor subunit-deficient mice to characterize nAChRs that modulate [3H]nore-pinephrine release from synaptosomes. The results indicate that at least two populations of nAChRs contribute to this release: a novel alpha6(alpha4)beta2beta3beta4 subtype and an alpha6(alpha4)beta2beta3 subtype. These are distinct from subtypes that modulate synaptosomal norepinephrine release in the rat hippocampus in which an alpha6/beta2 and/or alpha6/beta4 ligand binding interface is not present. Whereas alpha-conotoxin MII fully inhibits nicotine-evoked [3H]norepinephrine release in mouse, it is ineffective in blocking [3H]norepinephrine release in rat. Block of [3H]norepinephrine release by alpha-conotoxin BuIA, a toxin that kinetically distinguishes between beta2- and beta4-containing nAChRs, was partially reversible in mouse but irreversible in rat. This indicates that in contrast to rat, mouse nAChRs are made of both beta4 and non-beta4-containing populations. Results from beta2 and beta4 null mutant mice confirmed this conclusion, indicating the presence of the beta2 subunit in all nAChRs and the presence of the beta4 subunit in a subpopulation of nAChRs. In addition, both alpha4 and beta3 subunits are essential for the formation of functional nAChRs on mouse noradrenergic terminals. Cytisine, a ligand formerly believed to be beta4-selective, was a highly effective agonist for alpha6beta2-containing nAChRs. The sum of these results suggests a possible novel nAChR subtype that modulates nor-adrenergic neurotransmission within the mouse hippocampus.
Similar articles
-
Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.Br J Pharmacol. 1996 Feb;117(4):595-606. doi: 10.1111/j.1476-5381.1996.tb15232.x. Br J Pharmacol. 1996. PMID: 8646402 Free PMC article.
-
alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.J Neurosci. 1998 Nov 1;18(21):8571-9. doi: 10.1523/JNEUROSCI.18-21-08571.1998. J Neurosci. 1998. PMID: 9786965 Free PMC article.
-
Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.Br J Pharmacol. 2007 Jun;151(3):414-22. doi: 10.1038/sj.bjp.0707236. Epub 2007 Apr 2. Br J Pharmacol. 2007. PMID: 17401441 Free PMC article.
-
Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.Acta Pharmacol Sin. 2009 Jun;30(6):740-51. doi: 10.1038/aps.2009.63. Acta Pharmacol Sin. 2009. PMID: 19498417 Free PMC article. Review.
-
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. doi: 10.1016/j.bcp.2007.07.032. Epub 2007 Jul 27. Biochem Pharmacol. 2007. PMID: 17825262 Free PMC article. Review.
Cited by
-
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.Br J Pharmacol. 2013 Feb;168(4):835-49. doi: 10.1111/j.1476-5381.2012.02204.x. Br J Pharmacol. 2013. PMID: 22957729 Free PMC article.
-
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.Acta Pharmacol Sin. 2009 Jun;30(6):771-83. doi: 10.1038/aps.2009.47. Epub 2009 May 18. Acta Pharmacol Sin. 2009. PMID: 19448650 Free PMC article. Review.
-
α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.Mol Pharmacol. 2015 Nov;88(5):881-93. doi: 10.1124/mol.115.100982. Epub 2015 Sep 1. Mol Pharmacol. 2015. PMID: 26330550 Free PMC article.
-
Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.J Neurochem. 2012 Sep;122(6):1137-44. doi: 10.1111/j.1471-4159.2012.07867.x. Epub 2012 Aug 3. J Neurochem. 2012. PMID: 22774872 Free PMC article.
-
α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.Mol Pharmacol. 2012 Nov;82(5):972-82. doi: 10.1124/mol.112.080853. Epub 2012 Aug 22. Mol Pharmacol. 2012. PMID: 22914547 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources